✦ LIBER ✦

Isolated Chemotherapeutic Perfusion of Pelvis as Neoadjuvant or Palliative Therapy for Advanced Cancer of the Rectum

✍ Scribed by Harold J. Wanebo; Michael DiSiena; Giovanni Begossi; James Belliveau; Eric Gustafson

Book ID: 111772253
Publisher: Springer
Year: 2007
Tongue: English
Weight: 331 KB
Volume: 15
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-007-9652-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results and complications of surgery com

Results and complications of surgery combined with intra-operative radiation therapy for the treatment of locally advanced or recurrent cancers in the pelvis

✍ Kenneth S. Hu; Louis B. Harrison 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

Intra-operative radiation therapy (IORT) can benefit patients with pelvic tumors by delivering a high dose of radiation with precise delineation of tumor bed and maximal protection of surrounding normal tissues. The IORT experience has been particularly promising for locally advanced primary or recu

Hyperthermic isolated limb perfusion wit

Hyperthermic isolated limb perfusion with tumour necrosis factor α and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?

✍ A. F. T. Olieman; R. J. van Ginkel; W. M. Molenaar; H. Schraffordt Koops; H. J. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 86 KB

The use of high-dose cyclophosphamide, c

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy

✍ Yee Chung Cheng; Gabriela Rondón; Ying Yang; Terry L. Smith; James L. Gajewski; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Concurrent Bevacizumab with a Sequential

Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

✍ Priya Rastogi; Marc E. Buyse; Sandra M. Swain; Samuel A. Jacobs; André Robidoux; 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 570 KB

P-537 Cisplatin plus gemcitabine with or

P-537 Cisplatin plus gemcitabine with or without vinorelbine as neoadjuvant therapy for radically-treatable stage II non small cell lung cancer (NSCLC). Preliminary results of a randomised study of the GON (grupo Oncológico del Norte de Espan˜a)

✍ De Sande, Jose Luis; Esteban, Emilio; Fernández, Yolanda; Fra, Joaquin; Palacio, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Results of two open label Multicentre ph

Results of two open label Multicentre phase II pilot studies with Herceptin in combination with docetaxel and platinum salts (Cis or Carboplatin) (TCH) as Therapy for Advanced Breast Cancer (ABC) in women with tumors over-expressing the HER2-neu proto-oncogene

✍ J.-M. Nabholtz; T. Pienkowski; D. Nothfelt; W. Eiermann; E. Quan; P. Fumoleau; R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB